LATEST ALERTS
Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their inception.
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue
A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims”
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances
The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC
Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges
The Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has changed its mind over the regulatory framework established for cannabis products in late 2018
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis
Lawyers for the UK Cannabis Trades Association (CTA) have confirmed to CBD-Intel that they have not been instructed to sue the EU over novel food guidance for cannabinoids including CBD – contrary to reports
An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD companies
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change
Our latest regulatory report on CBD in Israel covers the hemp plant’s status, the import and export of finished product and much more.
Cannabis is a dangerous drug under Israeli criminal law; the possibility of legalising industrial hemp is presently being explored by the government. The legality of CBD products imported and distributed in Israel remains a grey area; the Ministry of Health considers CBD a dangerous drug while the police have declared it legal – while also decriminalising cannabis…
The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts
The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online
The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US
Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light
The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb
Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts
The French CBD market looks more promising as shops shut down last year through legal action have begun to re-open – though elsewhere in the country others are still being closed and their owners prosecuted
Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers
The United Nations Committee on Narcotic Drugs (UNCND) has delayed voting on cannabis and CBD recommendations in a move that has upset a number of delegates
Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain
Proper disposal of cannabis raw materials forms a major part of new work from ASTM International, US-based developer of international voluntary technical standards
In our latest look at CBD regulations in the Netherlands, we see that extraction and manufacture of CBD from hemp is forbidden, and while production and THC are prohibited CBD end-products are not specifically forbidden
According to EU authorities, CBD and other cannabis extracts could be deemed illegal as an ingredient in cosmetics. However, individual member states have not made the same interpretation of the rules
Lithuania could buck current European trends and legislate to allow CBD food products. A new bill allowing edibles with less than 0.2% THC content has been proposed in the country’s parliament
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert
More women than men have tried CBD products, according to a new report from CBD-Intel. Among other findings in the report is that health-conscious men are more likely than others to try CBD
While CBD is not specifically regulated in Serbia, CBD-Intel has found clear differences between legal theory and production practice, and confusion within the authorities, in a country that aims to join the EU in 2025
Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits
CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis
The health authorities in the Czech Republic are considering a proposal to cover up to 90% of the cost of medical cannabis through public insurance
The production of foods containing cannabinoids is not permitted in Italy, the country’s health ministry has confirmed to CBD-Intel
The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process
No one in Austria wants to take responsibility for the enforcement and clarification of CBD regulations as Austrian and European officials appear to be working at cross purposes to implement new rulings
The Austrian government is to review the enforcement of rules on CBD, but stricter interpretations are not expected despite recent rumours and the fears of some sellers of CBD products
The UK’s Food Standards Agency has said there will be no change in UK regulations concerning CBD as a novel food ingredient should the UK leave the EU on 29th March
A bill on the regulation of medical cannabis is currently being debated in the national legislature of Brazil, where CBD is a controlled substance and industrial hemp, like the cannabis plant, is banned
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Interest in the Greek CBD market continues to grow despite an uncertain regulatory situation, with a number of apparent cases of police taking action against people acting entirely legally
FOR IMMEDIATE RELEASE UK confirms it will not allow CBD foods and beverages even after Brexit Even Brexit may not be able to save UK CBD users following a change in European guidance. The European Food Safety Authority (EFSA) recently changed guidance on cannabinoids asserting that all food products using any cannabinoid should now have special authorisation under » Continue Reading.
This report covers the regulatory status of CBD-related products in Sweden
While the EU has allowed varieties of industrial hemp to be grown in Sweden in accordance with EU rules, cannabidiol extracts are currently widely subject to medicines legislation as interpreted by Sweden’s Medical Products Agency.
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
